Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells
暂无分享,去创建一个
D. Seol | J. Jessup | Tae-Hyoung Kim | T. Billiar | Yong J. Lee | H. Kim | H. Kim | Young-Keun Song | Kun‐Hsiung Lee | Lee Kh | Jessup Jm | Kim Th | Song Yk
[1] A. Winoto,et al. FADD Is Required for DR4- and DR5-mediated Apoptosis , 2000, The Journal of Biological Chemistry.
[2] B. Freeman,et al. Concentration-dependent Effects of Nitric Oxide on Mitochondrial Permeability Transition and Cytochrome cRelease* , 2000, The Journal of Biological Chemistry.
[3] D. Lawrence,et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.
[4] J. Blenis,et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.
[5] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[6] T. Billiar,et al. Cellular Non-heme Iron Content Is a Determinant of Nitric Oxide-mediated Apoptosis, Necrosis, and Caspase Inhibition* , 2000, The Journal of Biological Chemistry.
[7] T L Chenevert,et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Cavenee,et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. , 2000, Cancer research.
[9] T. Whiteside,et al. Identification of a Novel Tumor Necrosis Factor-α-inducible Gene, SCC-S2, Containing the Consensus Sequence of a Death Effector Domain of Fas-associated Death Domain-like Interleukin- 1β-converting Enzyme-inhibitory Protein* , 2000, The Journal of Biological Chemistry.
[10] Y. Gazitt,et al. Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2. , 1999, Cytokine.
[11] B. Brüne,et al. p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide , 1999, Oncogene.
[12] G. Brown,et al. Mitochondria Mediate Nitric Oxide‐Induced Cell Death , 1999, Annals of the New York Academy of Sciences.
[13] C. Richter,et al. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. , 1999, The Journal of biological chemistry.
[14] D. Lawrence,et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.
[15] S. Srinivasula,et al. Cytochrome c and dATP-mediated Oligomerization of Apaf-1 Is a Prerequisite for Procaspase-9 Activation* , 1999, The Journal of Biological Chemistry.
[16] T. Billiar,et al. Nitric Oxide Suppresses Apoptosis via Interrupting Caspase Activation and Mitochondrial Dysfunction in Cultured Hepatocytes* , 1999, The Journal of Biological Chemistry.
[17] X. Liu,et al. An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9* , 1999, The Journal of Biological Chemistry.
[18] V. Dixit,et al. Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.
[19] W. Dröge,et al. Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release. , 1999, Blood.
[20] S. Rocha,et al. Ceramide Induces Cytochrome c Release from Isolated Mitochondria , 1999, The Journal of Biological Chemistry.
[21] M. Nau,et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. , 1999, Cancer research.
[22] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[23] Emad S. Alnemri,et al. Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.
[24] Simon C Watkins,et al. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[25] M. Tohyama,et al. Involvement of Bcl‐2 Family and Caspase‐3‐Like Protease in NO‐Mediated Neuronal Apoptosis , 1998 .
[26] Y. Komada,et al. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. , 1998, Cellular immunology.
[27] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[28] A. Gurney,et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain , 1997, Current Biology.
[29] C. Smith,et al. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. , 1997, Immunity.
[30] R. Dubose,et al. Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family , 1997, The Journal of experimental medicine.
[31] R. Gentz,et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.
[32] T. Gura. How TRAIL Kills Cancer Cells, But Not Normal Cells , 1997, Science.
[33] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[34] G. Kroemer,et al. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition , 1997, FEBS letters.
[35] Arul M. Chinnaiyan,et al. The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.
[36] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[37] S. Marsters,et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.
[38] Jen-kun Lin,et al. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells , 1996, Molecular carcinogenesis.
[39] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[40] B. Spur,et al. Peroxynitrite-induced Apoptosis in HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.
[41] M. Weller,et al. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. , 1995, The Journal of clinical investigation.
[42] B. Brüne,et al. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. , 1995, Molecular pharmacology.
[43] J. Stamler,et al. Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.
[44] R. Ochs,et al. Chondrocyte apoptosis induced by nitric oxide. , 1995, The American journal of pathology.